Skip to main content
Clinical Trials/NCT04178408
NCT04178408
Recruiting
Not Applicable

Registry to Study the Incidence, Phenotype, Risk Factors and Clinical Course of Inflammatory Bowel Disease in Zimbabwe

University of Zimbabwe1 site in 1 country100 target enrollmentJanuary 2, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammatory Bowel Diseases
Sponsor
University of Zimbabwe
Enrollment
100
Locations
1
Primary Endpoint
Demographic and phenotypic features of inflammatory bowel disease
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.

Detailed Description

A prospective observational registry with a nested case-control study will be established at a gastrointestinal outpatient's clinic at a tertiary care hospital in Harare, Zimbabwe. The registry will recruit confirmed cases of inflammatory bowel disease from the clinic, other hospitals within and outside Harare, and from private practitioners. Two controls, a sibling or cousin, and an individual living in the same neighbourhood will also be recruited for each case. Demographic and clinical data will be obtained for all cases at baseline, after 6 months and annually thereafter. A questionnaire adapted from the International Organisation of IBD for risk factors of inflammatory bowel disease, and a food frequency questionnaire will be administered to all participants. Stool specimens, and germline DNA from peripheral blood will be biobanked in the Department of Medicine at the University of Zimbabwe. Preliminary data analysis will be carried out after at least 100 patients have been recruited. Descriptive statistics will be used to summarise data on demographic and phenotypic characteristics of inflammatory bowel disease, and incidence will be estimated for Harare. Risk factors for inflammatory bowel disease will be analysed using conditional logistic regression.

Registry
clinicaltrials.gov
Start Date
January 2, 2021
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any patient with confirmed inflammatory bowel disease
  • Onset of disease ≥3 months ago.
  • Age ≥ 18 years (NB - cases younger than 18 will be excluded from case-control analysis
  • One sibling or cousin (2nd degree) and one neighbourhood control.

Exclusion Criteria

  • Suspected inflammatory bowel disease
  • Unexplained gastrointestinal symptoms including diarrhoea, vomiting, chronic abdominal pain, weight loss, rectal bleeding, and recent change in bowel habit.
  • Previous unexplained gastrointestinal surgery

Outcomes

Primary Outcomes

Demographic and phenotypic features of inflammatory bowel disease

Time Frame: one year

Data on demographic (age, gender, ethnicity) and phenotypic (Crohn's disease versus ulcerative colitis, location, severity, extra-intestinal manifestations etc) will be collected using a standardised case report report forms

Secondary Outcomes

  • Risk factors of inflammatory bowel disease in Zimbabwe(Two years)
  • Dietary risk factors of inflammatory bowel disease in Zimbabwe(Two years)
  • Incidence and prevalence of inflammatory bowel disease in Zimbabwe(Three years)

Study Sites (1)

Loading locations...

Similar Trials